Arbaugh, the first patient to take part in the clinical trial of humans testing Elon Musk’s Neuralink device, plays Snake with the help of the Neuralink implant at home in Yuma, Arizona, on May 21, 2024. Musk and members of the Neuralink team detailed fixing an issue that saw Arbaugh's ability to move a computer cursor with his mind greatly reduced. — The New York Times
SAN FRANCISCO: Elon Musk on July 10 said his Neuralink startup is “moving on” to a second test patient as its tech for linking brains and computers improves.
Musk and members of the Neuralink team fielded questions during an update streamed on X, formerly Twitter, discussing where it is on the path to making its brain implants commonplace.
